Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials?

Alexandra Leary1, Ian Smith

  • 1Royal Marsden Hospital, London, UK.

Abstract

No abstract available in PubMed .

Related Concept Videos